Pure Global
NCT06420817

Effect of a Customised Lifestyle Medicine Strategy on Lowering Blood Lipid Levels in Indian Physicians

Jubilee Mission Medical College and Research Institute·ClinicalTrials.gov·behavioralRecruitment Completed
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Lifestyle Risk Reduction,Cholesterol, Elevated,LDL Hyperlipoproteinemia,Hypertension,Lipoprotein(A),HbA1C,BMI
Drug/Device/Intervention
Indian version of a 'Portfolio' diet
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Jubilee Mission Medical College and Research Institute
Location
Thrissur, India
Timeline & enrollment
Phase
N/A
Start date
Feb 15, 2024
End date
Aug 15, 2024
Enrollment
50 participants
Primary outcome

Changes in the blood lipid levels

Summary

Lifestyle medicine is a medical specialty that uses evidence-based therapeutic interventions
 to prevent, treat, and reverse chronic conditions. Studies have shown that a 50 mg/dl
 reduction in LDL reduces the risk of developing stroke by 20%, and a 10 mm Hg reduction in
 systolic BP reduces the risk of developing MACE by 22% and stroke by 41%. The CLIP
 (Cholesterol Lowering Lifestyle Intervention Project) is an innovative initiative proposed to
 evaluate the combined effect of an Indian version of Portfolio diet-based nutrition strategy,
 intermittent fasting, exercise, sleep, and stress reduction techniques on lowering blood
 lipid levels in health professionals and their family. The study aims to evaluate the effect
 of CLIP on changes in blood pressure, weight, HbA1C levels, blood CRP levels, and other blood
 parameters.

ICD-10 classifications
Other problems related to lifestylePure hypercholesterolaemiaSeeking and accepting physical, nutritional and chemical interventions known to be hazardous and harmfulOther adverse effects, not elsewhere classifiedOther disorders of lipoprotein metabolism
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06420817
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06420817 through Pure Global AI's free database. This phase not specified trial is sponsored by Jubilee Mission Medical College and Research Institute and is currently Recruitment Completed. The study focuses on Lifestyle Risk Reduction,Cholesterol, Elevated,LDL Hyperlipoproteinemia,Hypertension,Lipoprotein(A),HbA1C,BMI. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.